The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study
Background and Aims: Role of epidural dexmedetomidine in providing analgesia is well documented, but its effect on oxygenation and shunt fraction is not well established. We studied the hypothesis that epidural dexmedetomidine may improve oxygenation and shunt fraction during one-lung ventilation (O...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Anaesthesiology Clinical Pharmacology |
Subjects: | |
Online Access: | http://www.joacp.org/article.asp?issn=0970-9185;year=2016;volume=32;issue=4;spage=458;epage=464;aulast=Kar |
id |
doaj-aa135fb641794096a3c2ababb6451a06 |
---|---|
record_format |
Article |
spelling |
doaj-aa135fb641794096a3c2ababb6451a062020-11-24T21:11:09ZengWolters Kluwer Medknow PublicationsJournal of Anaesthesiology Clinical Pharmacology0970-91852016-01-0132445846410.4103/0970-9185.194771The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled studyPrachi KarPadmaja DurgaRamachandran GopinathBackground and Aims: Role of epidural dexmedetomidine in providing analgesia is well documented, but its effect on oxygenation and shunt fraction is not well established. We studied the hypothesis that epidural dexmedetomidine may improve oxygenation and shunt fraction during one-lung ventilation (OLV). Material and Methods: After taking Institutional Ethics Committee approval, sixty patients undergoing thoracotomy and OLV were randomized to receive epidural ropivacaine with saline (RS group) or epidural ropivacaine with dexmedetomidine (RD group). Group RS received 7 ml of ropivacaine 0.5% with 1.5 ml normal saline (NS) bolus while RD group received 7 ml of 0.5% ropivacaine with 1 mcg/kg dexmedetomidine reconstituted in 1.5 ml NS. This was followed by infusion of 5 ml/h of 0.5% ropivacaine in RS group and 5 ml/h of 0.5% ropivacaine containing 0.2 mcg/kg of dexmedetomidine in RD group. Arterial and central venous blood gas parameters were obtained 15 minutes after intubation during two lung ventilation (TLV15), 15 and 45 min after OLV (OLV15, OLV45) and 15 minutes after reinstitution of two lung ventilation (ReTLV). Results: RD group had better oxygenation (254.2 ± 72.3 mmHg, 240.60 ± 59.26 mmHg) as compared to RS group (215.2 ± 64.3 mmHg, 190.7 ± 61.48 mmHg) at OLV15 (P - 0.04) and OLV45 (P - 0.004) respectively. Shunt fraction in RD group was (30.31 ± 7.89%, 33.76 ± 8.89%) and (35.14 ± 7.58%, 39.57 ± 13.03%) in RS group at OLV15 and OLV45, respectively. The increase in the shunt fraction from TLV15 was significantly greater in RS group than RD group both at OLV15 (P - 0.03) and OLV45 (P - 0.03). The sevoflurane and fentanyl requirement was lower in RD group. Conclusion: Epidural dexmedetomidine improves oxygenation and reduces shunt fraction during OLV, in patients undergoing thoracotomy. It also reduces intraoperative anesthetic and analgesic requirement.http://www.joacp.org/article.asp?issn=0970-9185;year=2016;volume=32;issue=4;spage=458;epage=464;aulast=KarDexmedetomidineone lung ventilationoxygenationshunt fractionthoracotomy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Prachi Kar Padmaja Durga Ramachandran Gopinath |
spellingShingle |
Prachi Kar Padmaja Durga Ramachandran Gopinath The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study Journal of Anaesthesiology Clinical Pharmacology Dexmedetomidine one lung ventilation oxygenation shunt fraction thoracotomy |
author_facet |
Prachi Kar Padmaja Durga Ramachandran Gopinath |
author_sort |
Prachi Kar |
title |
The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study |
title_short |
The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study |
title_full |
The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study |
title_fullStr |
The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study |
title_full_unstemmed |
The effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: A randomized controlled study |
title_sort |
effect of epidural dexmedetomidine on oxygenation and shunt fraction in patients undergoing thoracotomy and one lung ventilation: a randomized controlled study |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Anaesthesiology Clinical Pharmacology |
issn |
0970-9185 |
publishDate |
2016-01-01 |
description |
Background and Aims: Role of epidural dexmedetomidine in providing analgesia is well documented, but its effect on oxygenation and shunt fraction is not well established. We studied the hypothesis that epidural dexmedetomidine may improve oxygenation and shunt fraction during one-lung ventilation (OLV).
Material and Methods: After taking Institutional Ethics Committee approval, sixty patients undergoing thoracotomy and OLV were randomized to receive epidural ropivacaine with saline (RS group) or epidural ropivacaine with dexmedetomidine (RD group). Group RS received 7 ml of ropivacaine 0.5% with 1.5 ml normal saline (NS) bolus while RD group received 7 ml of 0.5% ropivacaine with 1 mcg/kg dexmedetomidine reconstituted in 1.5 ml NS. This was followed by infusion of 5 ml/h of 0.5% ropivacaine in RS group and 5 ml/h of 0.5% ropivacaine containing 0.2 mcg/kg of dexmedetomidine in RD group. Arterial and central venous blood gas parameters were obtained 15 minutes after intubation during two lung ventilation (TLV15), 15 and 45 min after OLV (OLV15, OLV45) and 15 minutes after reinstitution of two lung ventilation (ReTLV).
Results: RD group had better oxygenation (254.2 ± 72.3 mmHg, 240.60 ± 59.26 mmHg) as compared to RS group (215.2 ± 64.3 mmHg, 190.7 ± 61.48 mmHg) at OLV15 (P - 0.04) and OLV45 (P - 0.004) respectively. Shunt fraction in RD group was (30.31 ± 7.89%, 33.76 ± 8.89%) and (35.14 ± 7.58%, 39.57 ± 13.03%) in RS group at OLV15 and OLV45, respectively. The increase in the shunt fraction from TLV15 was significantly greater in RS group than RD group both at OLV15 (P - 0.03) and OLV45 (P - 0.03). The sevoflurane and fentanyl requirement was lower in RD group.
Conclusion: Epidural dexmedetomidine improves oxygenation and reduces shunt fraction during OLV, in patients undergoing thoracotomy. It also reduces intraoperative anesthetic and analgesic requirement. |
topic |
Dexmedetomidine one lung ventilation oxygenation shunt fraction thoracotomy |
url |
http://www.joacp.org/article.asp?issn=0970-9185;year=2016;volume=32;issue=4;spage=458;epage=464;aulast=Kar |
work_keys_str_mv |
AT prachikar theeffectofepiduraldexmedetomidineonoxygenationandshuntfractioninpatientsundergoingthoracotomyandonelungventilationarandomizedcontrolledstudy AT padmajadurga theeffectofepiduraldexmedetomidineonoxygenationandshuntfractioninpatientsundergoingthoracotomyandonelungventilationarandomizedcontrolledstudy AT ramachandrangopinath theeffectofepiduraldexmedetomidineonoxygenationandshuntfractioninpatientsundergoingthoracotomyandonelungventilationarandomizedcontrolledstudy AT prachikar effectofepiduraldexmedetomidineonoxygenationandshuntfractioninpatientsundergoingthoracotomyandonelungventilationarandomizedcontrolledstudy AT padmajadurga effectofepiduraldexmedetomidineonoxygenationandshuntfractioninpatientsundergoingthoracotomyandonelungventilationarandomizedcontrolledstudy AT ramachandrangopinath effectofepiduraldexmedetomidineonoxygenationandshuntfractioninpatientsundergoingthoracotomyandonelungventilationarandomizedcontrolledstudy |
_version_ |
1716754314322509824 |